Actively Recruiting
Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Led by Universidade Federal Fluminense · Updated on 2025-04-04
30
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).
CONDITIONS
Official Title
Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with chronic kidney disease undergoing hemodialysis for more than 6 months
- Patients using arteriovenous fistula as vascular access
You will not qualify if you...
- Pregnant individuals
- Lactating individuals
- Smokers
- Patients who have used antibiotics or antioxidant supplements in the last three months
- Patients with autoimmune or infectious diseases
- Patients with cancer, liver disease, or AIDS
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Denise Mafra
Rio de Janeiro, Rio de Janeiro, Brazil, 22260050
Actively Recruiting
Research Team
D
Denise Mafra
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here